Deutsche Bank
IBIO icon

Deutsche Bank’s iBio IBIO Stock Holding History

Deutsche Bank’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-235
Closed -$50K – 4215
2022
Q1 		$50K Sell
235
-28
-11% -$5.86K ﹤0.01% 3844
2021
Q4 		$72K Buy
263
+14
+6% +$5.34K ﹤0.01% 3840
2021
Q3 		$132K Sell
249
-4
-2% -$2.49K ﹤0.01% 3769
2021
Q2 		$191K Sell
253
-14
-5% -$10.2K ﹤0.01% 3811
2021
Q1 		$206K Buy
267
+9
+3% +$7.84K ﹤0.01% 3618
2020
Q4 		$136K Buy
258
+194
+303% +$158K ﹤0.01% 3677
2020
Q3 		$65K Buy
64
+14
+28% +$20.3K ﹤0.01% 3748
2020
Q2 		$55K Buy
+50
New +$32.7K ﹤0.01% 3766
2019
Q1 		– Hold
0
– – – 5289
2018
Q4 		– Hold
0
– – – 5258
2014
Q1 		– Hold
0
– – – 5681
2013
Q4 		– Hold
0
– – – 5525
2013
Q3 		– Hold
0
– – – 5614

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank's IBIO Position: Q2 2022 in Review

Deutsche Bank sold out of iBio (IBIO) in Q2 2022, closing a stake of 235 shares — an estimated $50K sold.

Deutsche Bank first reported a position in IBIO in Q2 2020 and held it in 8 quarters. The position peaked at $206K in Q1 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • Deutsche Bank reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 235 iBio shares in Q2 2022, an estimated $50K.
  • Deutsche Bank first reported a position in iBio in Q2 2020 and held it in 8 quarters.
  • Deutsche Bank's iBio position peaked at $206K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.